Department of Pharmacology, Baylor College of Medicine, Houston, Texas 77030, USA.
J Biol Chem. 2011 Sep 16;286(37):32723-35. doi: 10.1074/jbc.M111.265058. Epub 2011 Jul 20.
β-Lactamases hydrolyze β-lactam antibiotics to provide drug resistance to bacteria. β-Lactamase inhibitory protein-II (BLIP-II) is a potent proteinaceous inhibitor that exhibits low picomolar affinity for class A β-lactamases. This study examines the driving forces for binding between BLIP-II and β-lactamases using a combination of presteady state kinetics, isothermal titration calorimetry, and x-ray crystallography. The measured dissociation rate constants for BLIP-II and various β-lactamases ranged from 10(-4) to 10(-7) s(-1) and are comparable with those found in some of the tightest known protein-protein interactions. The crystal structures of BLIP-II alone and in complex with Bacillus anthracis Bla1 β-lactamase revealed no significant side-chain movement in BLIP-II in the complex versus the monomer. The structural rigidity of BLIP-II minimizes the loss of the entropy upon complex formation and, as indicated by thermodynamics experiments, may be a key determinant of the observed potent inhibition of β-lactamases.
β-内酰胺酶水解β-内酰胺抗生素,从而使细菌产生耐药性。β-内酰胺酶抑制蛋白-II(BLIP-II)是一种强效的蛋白抑制剂,对 A 类β-内酰胺酶表现出低皮摩尔亲和力。本研究使用预稳态动力学、等温滴定量热法和 X 射线晶体学相结合的方法,研究了 BLIP-II 与β-内酰胺酶之间结合的驱动力。BLIP-II 和各种β-内酰胺酶的测量解离速率常数范围为 10(-4) 到 10(-7) s(-1),与一些已知最紧密的蛋白-蛋白相互作用相当。BLIP-II 单独和与炭疽芽孢杆菌 Bla1 β-内酰胺酶复合物的晶体结构显示,在复合物与单体相比,BLIP-II 中没有明显的侧链运动。BLIP-II 的结构刚性最小化了在复合物形成过程中熵的损失,热力学实验表明,这可能是观察到对β-内酰胺酶的强烈抑制的关键决定因素。